Competing risks of death in younger and older postmenopausal breast cancer patients

Table 4 Survival at 5 and 10 yr

Factor	5 yr1	10 yr1
Breast cancer survival
Treatment
Tamoxifen	0.94	0.85
Tamoxifen + Octreotide LAR	0.94	0.85
Tumour size
T1	0.96	0.89
≥ T2, unknown	0.90	0.78
Nodal status
N0	0.96	0.89
N1, N2, Nx	0.90	0.78
Other cause survival
Treatment
Tamoxifen	0.98	0.94
Tamoxifen + Octreotide LAR	0.99	0.95
Age
60	0.99	0.95
70	0.97	0.90
BMI
25	0.99	0.96
30	0.98	0.94
35	0.98	0.91
40	0.97	0.88
45	0.95	0.84

¹Survival for is adjusted for the effects of other factors: treatment, stratification and other significant factors.